Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma

Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Bioorganic & Medicinal Chemistry Letters - Volume 27, Issue 8, 15 April 2017, Pages 1744-1749

Kim M. Hutchings, Erika M. Lisabeth, Walajapet Rajeswaran, Michael W. Wilson, Roderick J. Sorenson, Phillip L. Campbell, Jeffrey H. Ruth, Asif Amin, Pei-Suen Tsou, Jeffrey R. Leipprandt, Samuel R. Olson, Bo Wen, Ting Zhao, Duxin Sun, Dinesh Khanna,